• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function.

作者信息

Holm R, Jensen I H M, Sonnergaard J

机构信息

Pharmaceutical Research and Development, H.Lundbeck A/S, Ottilavej, 92500, Valby, Denmark.

出版信息

Drug Dev Ind Pharm. 2006 Oct;32(9):1025-32. doi: 10.1080/03639040600559024.

DOI:10.1080/03639040600559024
PMID:17012115
Abstract

D-optimal design and the desirability function were applied to optimize a self-microemulsifying drug delivery system (SMEDDS). The optimized key parameters were the following: 1) particle size of the dispersed emulsion, 2) solubility of the drug in the vehicle, and 3) the vehicle compatibility with the hard gelatin capsule. Three formulation variables, PEG200, a surfactant mixture, and an oil mixture, were included in the experimental design. The results of the mathematical analysis of the data demonstrated significant interactions among the formulation variables, and the desirability function was demonstrated to be a powerful tool to predict the optimal formulation for the explored system.

摘要

相似文献

1
Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function.
Drug Dev Ind Pharm. 2006 Oct;32(9):1025-32. doi: 10.1080/03639040600559024.
2
Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function.采用 Box-Behnken 设计和可满意度函数优化替米沙坦自微乳给药系统。
J Pharm Pharmacol. 2013 Oct;65(10):1440-50. doi: 10.1111/jphp.12115. Epub 2013 Jul 24.
3
Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.司骨化醇II的生物利用度:含中链和长链甘油三酯的口服自微乳化药物递送系统(SMEDDS)的开发与特性研究
Eur J Pharm Sci. 2006 Jun;28(3):233-42. doi: 10.1016/j.ejps.2006.02.005. Epub 2006 May 2.
4
Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir.用于口服阿昔洛韦的自微乳化药物递送系统(SMEDDSs)设计与区分中关键制剂参数的评估。
Int J Pharm. 2016 Jan 30;497(1-2):301-11. doi: 10.1016/j.ijpharm.2015.11.011. Epub 2015 Dec 1.
5
Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.采用D-最优混合设计法开发并优化阿托伐他汀钙自微乳化药物递送系统
Int J Nanomedicine. 2015 Jun 5;10:3865-77. doi: 10.2147/IJN.S83520. eCollection 2015.
6
Preparation and evaluation of valsartan by a novel semi-solid self-microemulsifying delivery system using Gelucire 44/14.使用Gelucire 44/14通过新型半固体自微乳化给药系统制备和评价缬沙坦。
Drug Dev Ind Pharm. 2016 Oct;42(10):1545-52. doi: 10.3109/03639045.2016.1151034. Epub 2016 Mar 4.
7
Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.混合脂质相 SMEDDS 作为一种提高白藜芦醇溶解度的创新方法。
Drug Dev Ind Pharm. 2014 Jan;40(1):102-9. doi: 10.3109/03639045.2012.749888. Epub 2013 Jan 10.
8
Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.Box-Behnken 设计在理解染料木黄酮自微乳给药系统质量及其制剂优化中的应用。
Pharm Dev Technol. 2009;14(6):642-9. doi: 10.3109/10837450902882385.
9
Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235).用 D-最优混合设计法制备自微乳药物传递系统(SMEDDS)以提高新型组织蛋白酶 K 抑制剂(HL235)的口服生物利用度。
Int J Pharm. 2020 Jan 5;573:118772. doi: 10.1016/j.ijpharm.2019.118772. Epub 2019 Nov 23.
10
Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.自微乳药物传递系统(SMEDDS)——挑战与展望。
Drug Deliv. 2015;22(6):675-90. doi: 10.3109/10717544.2014.896058. Epub 2014 Mar 27.

引用本文的文献

1
Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs.用于改善难溶性药物递送的胶囊型脂质口服制剂。
Front Drug Deliv. 2023 Aug 24;3:1232012. doi: 10.3389/fddev.2023.1232012. eCollection 2023.
2
An approach for an enhanced anticancer activity of ferulic acid-loaded polymeric micelles via MicroRNA-221 mediated activation of TP53INP1 in caco-2 cell line.载阿魏酸聚合物胶束通过 MicroRNA-221 介导的 caco-2 细胞系中 TP53INP1 的激活增强阿魏酸的抗癌活性的方法。
Sci Rep. 2024 Jan 24;14(1):2073. doi: 10.1038/s41598-024-52143-y.
3
Self-emulsifying Drug Delivery System for Improved Dissolution and Oral Absorption of Quetiapine Fumarate: Investigation of Drug Release Mechanism and Intestinal Permeability.
用于改善富马酸喹硫平溶解和口服吸收的自乳化药物递送系统:药物释放机制及肠道通透性研究
Iran J Pharm Res. 2021 Summer;20(3):381-398. doi: 10.22037/ijpr.2021.114785.15032.
4
Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy.响应面法优化载双醋瑞因的超弹性纳米囊用于经皮给药:增强生物利用度和抗炎疗效。
Int J Nanomedicine. 2021 Jan 25;16:591-607. doi: 10.2147/IJN.S276330. eCollection 2021.
5
Induced Pluripotent Stem Cell-Derived Endothelial Networks Accelerate Vascularization But Not Bone Regeneration.诱导多能干细胞衍生的内皮网络加速血管化但不促进骨再生。
Tissue Eng Part A. 2021 Jul;27(13-14):940-961. doi: 10.1089/ten.TEA.2020.0200. Epub 2020 Oct 19.
6
Optimization of self-microemulsifying drug delivery system for phospholipid complex of telmisartan using D-optimal mixture design.采用 D-最优混合设计优化替米沙坦磷脂复合物自微乳给药系统。
PLoS One. 2018 Dec 5;13(12):e0208339. doi: 10.1371/journal.pone.0208339. eCollection 2018.
7
Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.采用D-最优混合设计法开发并优化阿托伐他汀钙自微乳化药物递送系统
Int J Nanomedicine. 2015 Jun 5;10:3865-77. doi: 10.2147/IJN.S83520. eCollection 2015.
8
Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.基于微乳的抗真菌凝胶递送至指甲以治疗甲真菌病:制剂、优化和疗效研究。
Drug Deliv Transl Res. 2012 Dec;2(6):463-76. doi: 10.1007/s13346-012-0109-8.
9
Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies.二乙烯三胺五乙酸(DTPA)五乙酯前药的固体分散体:制剂设计与优化研究
Pharm Dev Technol. 2014 Nov;19(7):806-12. doi: 10.3109/10837450.2013.836216. Epub 2013 Sep 19.
10
Statistical Design of Experiments on Fabrication of Bilayer Tablet of Narrow Absorption Window Drug: Development and In vitro characterisation.窄吸收窗药物双层片制备实验的统计设计:研发与体外特性研究
Indian J Pharm Sci. 2012 Jul;74(4):302-11. doi: 10.4103/0250-474X.107049.